Stockreport

Earnings To Watch: Aytu BioPharma Inc (AYTU) Reports Q2 2026 Result [Yahoo! Finance]

Aytu BioPharma, Inc.  (AYTU) 
NASDAQ:AMEX Investor Relations: aytubio.com/investors/stock-information
PDF The consensus estimate for Q2 2026 revenue is $12.17 million, and the earnings are expected to come in at -$0.49 per share. The full year 2026's revenue is expected to b [Read more]